Clinical Research Chemotherapy Treatment Chairs
We are building a new comprehensive specialist cancer hospital in the centre of Liverpool, and require two clinical research chemotherapy treatment chairs, which will enable us to pioneer the use of new forms of chemotherapy and give our patients access to the most advanced treatments available.
January 2016 - October 2018
The Clatterbridge Cancer Charity
With the incidence of cancer increasing there is a fundamental need to continue to invest in pioneering research. Ground-breaking research needs to be continually progressed in order for new therapies to be developed, so that we are able to further understand cancer, leading to innovative treatments.
Cancer patients deserve to be treated with the most leading-edge equipment available, which is comfortable and offers precise patient positioning, especially when undergoing lengthy treatment.
Early phase, first in human clinical trials will be delivered from the chairs, meaning that our patients will benefit from the most advanced forms of cancer treatment available, maximising their choice of options.
The chairs will support our complex chemotherapy treatment of almost 56,000 deliveries by 2018 and 66,000 by 2022. It is imperative that all of these are delivered to patients using revolutionary equipment that optimises mobility and provide outstanding comfort and safety.
Increase the number of chemotherapy treatment options available to patients
Activities» We will invest in research to ensure that new therapies are continually developed
» Provide patients with a range of first in human clinical trials as and when they are available
» More trials means that our patients will have access quicker access to novel therapies
The number of our chemotherapy treatments will have increased with our ability to offer first in human clinical trials in the new hospital.
Achieve breakthroughs in cancer care and treatment
Activities» Increase and develop our first-class chemotherapy research portfolio
» Undertake pioneering research to help understand and treat cancer
» Work collaboratively with research partners, e.g. Merseyside and Cheshire Cancer Research Network and the University of Liverpool
» Disseminate key research findings to the wider cancer sector
Delivering clinical trials that help to inform the cancer sector across the world, and also achieve better outcomes for the patient.
Treat our chemotherapy patients with precise positioning, comfort and safety
Activities» We will invest in leading edge specialist chemotherapy treatment chairs
» Allow for rapid and easy adjustment from sitting to reclining, in the event of the patient fainting, or losing balance, during treatment
» Offer high comfort and stability, particularly as some patients have to regularly spend eight hours at a time a chair when undergoing treatment
» Improve patient experience of care, achieving better outcomes
Patient and staff feedback, which indicates that the chairs provide outstanding comfort, stability, mobility and effective delivery of treatment.
The chairs will form part of our Transforming Cancer Care (new hospital) project, which will totally change the way we deliver cancer services to a population of 2.3 million people across Merseyside and Cheshire.
Success of the research will be demonstrated through improved patient quality of life and development of new innovative treatments.
Patient/staff feedback will demonstrate the success of the chairs use, comfort and safety.
• Inadequate Research – Each clinical trial undertaken using the chairs will have a designated Principal Investigator and team of researchers, ensuring that the research is pioneering, of the highest quality and in line with the necessary guidelines.
• Unsuitable Chairs – We will ensure that we have the most advanced specialist chemotherapy chairs available that maximise cancer care and treatment, whilst achieving better outcomes for the patient.
We work closely with all our donors to update them on progress, for example written reports, exclusive visits to our research labs, meetings with our Research Manager to learn about the wide range of clinical trials being undertaken, and a behind the scenes tour of the new hospital.
Budget - Project Cost: £20,000Loading graph....
Amount Heading Description £10,000 Treatment chair Clinical Research Chemotherapy Treatment Chair £10,000 Treatment chair Clinical Research Chemotherapy Treatment Chair
The hospital will be an expansion of our services into the centre of Liverpool, putting us at the heart of the population we serve. 70% of our 30,000 patients currently travel to our Wirral site from north of the River Mersey. Cancer touches all of us at some point with one in two expected to develop the disease over our lifetime. You are 20% more likely to die of cancer if you live in Merseyside/Cheshire compared to the rest of the UK, with it being the number one cause of death in the region.
Our patients will directly benefit from receiving the latest and most advanced forms of cancer treatment. Patients’ family members/loved ones will indirectly benefit, with reduced anxiety and improved mental well-being, safe in the knowledge that they are receiving treatment that could improve their quality of life.
The wider clinical/cancer population will benefit from new innovative, refined and bespoke chemotherapy treatments being developed, as a direct result of the research findings.
The Clatterbridge Cancer Centre is a UK leader in the delivery of cancer care and is a centre of excellence for innovative cancer research. Our internationally renowned team of specialists are at the forefront in many areas of cancer research and are making breakthroughs in how we diagnose, treat and monitor cancer, resulting in new treatments. Patients have access to over 170 clinical trials at any one time, maximising their choice of treatment options.
Read more about the Charity running this project.
Dr Maria Maguire – Research Manager
Leads a team of researchers undertaking clinical trials.
Fiona Courtnell – Chemotherapy Manager
Responsible for the quality of care given to patients receiving chemotherapy treatment.